Related Experiment Video

Updated: Aug 16, 2026

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
15:45

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice

Published on: February 10, 2013

[Hemodynamic changes in patients with myocardial infarct complicated by acute left ventricular failure during

L I Ol'binskaia, V N Poptsov, A M Gofman

    Kardiologiia
    |April 1, 1991
    PubMed

    Insights

    Intravenous nitroglycerin improved hemodynamics in acute myocardial infarction patients with left ventricular failure. However, for those with low blood pressure, a combination of nitroglycerin and dobutamine is needed for hemodynamic normalization.

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Acute myocardial infarction can lead to acute left ventricular failure.
    • Central hemodynamics are critical indicators in managing cardiac emergencies.

    Purpose of the Study:

    • To evaluate the hemodynamic effects of intravenous nitroglycerin in patients with acute myocardial infarction and left ventricular failure.
    • To determine the efficacy of combined nitroglycerin and dobutamine therapy in specific patient subgroups.

    Main Methods:

    • Central hemodynamic monitoring was performed on 18 patients.
    • Intravenous nitroglycerin was administered to assess its impact on hemodynamic parameters.
    • A combined nitroglycerin and dobutamine solution was used in a subset of patients.

    Main Results:

    • Nitroglycerin improved central hemodynamic parameters but did not normalize them in patients with baseline low blood pressure.
    • Nitroglycerin further reduced blood pressure in hypotensive patients.
    • Combined nitroglycerin and dobutamine administration led to hemodynamic normalization.

    Conclusions:

    • Intravenous nitroglycerin offers partial hemodynamic benefits in acute myocardial infarction with left ventricular failure.
    • Combined nitroglycerin and dobutamine therapy is indicated for patients with baseline low blood pressure experiencing acute myocardial infarction complicated by left ventricular failure.

    More Related Videos

    Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats06:32

    Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

    Published on: June 28, 2019

    Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs08:19

    Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs

    Published on: July 12, 2022

    Related Concept Videos

    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

    The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
    Heart Failure Drugs: β-Blockers01:22

    Heart Failure Drugs: β-Blockers

    β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
    Antianginal Drugs: Nitrates and β-Blockers01:16

    Antianginal Drugs: Nitrates and β-Blockers

    In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
    Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
    Heart Failure II: Pathophysiology01:29

    Heart Failure II: Pathophysiology

    Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
    Heart Failure V: Medical Management01:30

    Heart Failure V: Medical Management

    Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...